Erin E. Mulvihill

5.2k total citations · 1 hit paper
68 papers, 3.8k citations indexed

About

Erin E. Mulvihill is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Erin E. Mulvihill has authored 68 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Surgery and 22 papers in Molecular Biology. Recurrent topics in Erin E. Mulvihill's work include Diabetes Treatment and Management (23 papers), Pancreatic function and diabetes (19 papers) and Adipose Tissue and Metabolism (12 papers). Erin E. Mulvihill is often cited by papers focused on Diabetes Treatment and Management (23 papers), Pancreatic function and diabetes (19 papers) and Adipose Tissue and Metabolism (12 papers). Erin E. Mulvihill collaborates with scholars based in Canada, United States and France. Erin E. Mulvihill's co-authors include Daniel J. Drucker, Murray W. Huff, Laurie L. Baggio, Julia M. Assini, Xiemin Cao, Jonathan E. Campbell, Cynthia G. Sawyez, Brian G. Sutherland, Amy C. Burke and Jane Y. Edwards and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Erin E. Mulvihill

66 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors

2014 454 citations Erin E. Mulvihill, Daniel J. Drucker profile →

Peers

Countries citing papers authored by Erin E. Mulvihill

Since Specialization

Citations

This map shows the geographic impact of Erin E. Mulvihill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin E. Mulvihill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin E. Mulvihill more than expected).

Fields of papers citing papers by Erin E. Mulvihill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin E. Mulvihill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin E. Mulvihill. The network helps show where Erin E. Mulvihill may publish in the future.

Co-authorship network of co-authors of Erin E. Mulvihill

This figure shows the co-authorship network connecting the top 25 collaborators of Erin E. Mulvihill. A scholar is included among the top collaborators of Erin E. Mulvihill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin E. Mulvihill. Erin E. Mulvihill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Translating metabolic and cardiovascular research into effective treatments: What’s next? 2024 ·Cell ·Juleen R. Zierath, Jolanda van der Velden, Ali Javaheri, Anthony Rosenzweig, Deborah M. Muoio, Erin E. Mulvihill, Tami A. Martino, Adil Rasheed, Xiaowei Chen, Zoltàn Arany	1
2	Myokine Secretion following an Aerobic Exercise Intervention in Individuals with Type 2 Diabetes with or without Exercise Resistance 2024 ·International Journal of Molecular Sciences ·Léa Garneau, Erin E. Mulvihill, Steven R. Smith, Lauren M. Sparks, Céline Aguer	5
3	Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches 2024 ·Journal of Pharmacy & Pharmaceutical Sciences ·(unknown), Erin E. Mulvihill	4
4	Thermoneutral housing does not accelerate metabolic dysfunction-associated fatty liver disease in male or female C57Bl/6J mice fed a Western diet 2023 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), (unknown), Peyman Ghorbani, Conor O’Dwyer, (unknown), (unknown), (unknown), Marisa K. Kilgour, Erin E. Mulvihill, Morgan D. Fullerton	9
5	Ketone ester administration improves glycemia in obese mice 2023 ·American Journal of Physiology-Cell Physiology ·(unknown), (unknown), (unknown), (unknown), Amanda A. Greenwell, (unknown), (unknown), (unknown), (unknown), Farah Eaton, Peter A. Crawford, Keshav Gopal, Erin E. Mulvihill, John R. Ussher	9
6	Exercise training reduces circulating cytokines in male patients with coronary artery disease and type 2 diabetes: A pilot study 2023 ·Physiological Reports ·Léa Garneau, Tasuku Terada, (unknown), Erin E. Mulvihill, Jennifer L. Reed, Céline Aguer	9
7	miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages 2022 ·Circulation Research ·My-Anh Nguyen, Huy‐Dung Hoang, Adil Rasheed, Anne‐Claire Duchez, Hailey Wyatt, (unknown), Tyson E. Graber, Leah C. Susser, Sabrina Robichaud, (unknown), Michèle Geoffrion, Mireille Ouimet, Hilal Kazan, Lars Mäegdefessel, Erin E. Mulvihill, Tommy Alain, Katey J. Rayner	42
8	Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis 2022 ·Molecular Metabolism ·(unknown), (unknown), (unknown), Jordan Sim, Xiaoling Zhao, (unknown), Alix Denoncourt, Angela Cheung, Michael Downey, Erin E. Mulvihill, Kyoung-Han Kim	64
9	Quantification of murine myocardial infarct size using 2-D and 4-D high-frequency ultrasound 2022 ·American Journal of Physiology-Heart and Circulatory Physiology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Joseph M. Gruber, Abigail Cox, Ilka Lorenzen‐Schmidt, Richard J. Seymour, Kyoung-Han Kim, Craig J. Goergen, Erin E. Mulvihill	12
10	Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein 2022 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Ghazaleh Eskandari‐Sedighi, Serene Wohlgemuth, My-Anh Nguyen, Daniel J. Drucker, Erin E. Mulvihill, David Westaway	5
11	14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells 2022 ·JCI Insight ·Yves Mugabo, Cheng Zhao, (unknown), Anindya Ghosh, S. Campbell, (unknown), Frédéric Paré, (unknown), (unknown), Julia Ast, Johannes Broichhagen, David J. Hodson, Erin E. Mulvihill, Sophie Petropoulos, Gareth E. Lim	17
12	Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases 2020 ·Frontiers in Genetics ·(unknown), (unknown), Erin E. Mulvihill, Kyoung-Han Kim	34
13	Distinct Neural Sites of GLP-1R Expression Mediate Physiological versus Pharmacological Control of Incretin Action 2019 ·Cell Reports ·Elodie M. Varin, Erin E. Mulvihill, Laurie L. Baggio, Jacqueline A. Koehler, Xiemin Cao, Randy J. Seeley, Daniel J. Drucker	83
14	Thermogenesis-independent metabolic benefits conferred by isocaloric intermittent fasting in ob/ob mice 2019 ·Scientific Reports ·(unknown), Ju Hee Lee, Joanna Yeung, (unknown), (unknown), Yanqing Jiang, Joon Ho Moon, (unknown), (unknown), Joe Eun Son, (unknown), Chi‐chung Hui, Kyung‐Oh Doh, Erin E. Mulvihill, Jae‐Ryong Kim, Kyoung-Han Kim, Hoon‐Ki Sung	34
15	Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2 2018 ·Current Opinion in Lipidology ·Erin E. Mulvihill	18
16	Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection 2014 ·Molecular Metabolism ·John R. Ussher, Laurie L. Baggio, Jonathan E. Campbell, Erin E. Mulvihill, Minsuk Kim, M. Golam Kabir, Xiemin Cao, (unknown), Doris A. Stoffers, Randy J. Seeley, Daniel J. Drucker	106
17	Citrus Flavonoids and the Prevention of Atherosclerosis 2012 ·Cardiovascular & Haematological Disorders - Drug Targets ·Erin E. Mulvihill, Murray W. Huff	34
18	Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr mice 2012 ·Journal of Lipid Research ·Julia M. Assini, Erin E. Mulvihill, Brian G. Sutherland, Dawn E. Telford, Cynthia G. Sawyez, (unknown), (unknown), Jane Y. Edwards, Robert Gros, Murray W. Huff	113
19	Antiatherogenic properties of flavonoids: Implications for cardiovascular health 2010 ·Canadian Journal of Cardiology ·Erin E. Mulvihill, Murray W. Huff	136
20	Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor 2008 ·Journal of Lipid Research ·Emma M. Allister, Erin E. Mulvihill, P. Hugh R. Barrett, Jane Y. Edwards, (unknown), Murray W. Huff	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact